Legend Biotech (NASDAQ:LEGN – Get Free Report) released its earnings results on Monday. The company reported ($0.40) EPS for the quarter, topping the consensus estimate of ($0.70) by $0.30, Briefing.com reports. The firm had revenue of $76.50 million during the quarter, compared to analysts’ expectations of $95.63 million. Legend Biotech had a negative net margin […]
Stock Market Live Updates - The Hindu BusinessLine thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
Legend Biotech Corporation (LEGN) announced Loss for fourth quarter that beat the Street estimates. The company's earnings came in at -$144.818 million, or -$0.